Andrew Hotchkiss is the founder of Draupnir Bio. Draupnir Bio has raised $13M in total funding. Based in Copenhagen, Denmark.
Andrew Hotchkiss joined Draupnir Bio as Chief Executive Officer in June 2021. He brings over 30 years of global experience in the pharmaceutical and biotechnology industries. His background includes leadership roles at Dermira and Immunocore, and over three decades at Eli Lilly and Company.
Full founder directory · Investor directory · Company funding database · Fundraising library